Japanese drugmaker Shionogi's president
Isao Teshirogi (C), president of Japanese pharmaceutical firm Shionogi & Co., attends a press conference in Tokyo on March 4, 2022, over the company's COVID-19 vaccine under development.
- Product Code
- ILEA000934839
- Registered date
- 2022/3/04 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media source
- 2022 Kyodo News
- Media size
- 3958 × 2806 pixel
- Deployment size
- 649.51(KB)*
*File size when opened in Photoshop, etc.